An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug – Paxlovid – is intended for use soon after symptoms develop in people at high risk of severe disease.
Pfizer says it stopped trials early as the initial results were so positive.
It comes the day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
Please subscribe HERE http://bit.ly/1rbfUog
#Covid #BBCNews
TikTok's Chinese owner ByteDance has signed binding agreements with US and global investors to sell the majority of its business…
L'edizione della notte del Tg diretto da Enrico Mentana
The Bank of England has cut interest rates to the lowest level since early 2023. UK Chancellor Rachel Reeves calls…
US President Donald Trump said a Ukraine peace deal is "closer than ever" following talks in Berlin with European officials…